Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01484938 |
|
Recruitment Status :
Completed
First Posted : December 5, 2011
Results First Posted : October 8, 2012
Last Update Posted : October 10, 2012
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Refractive Error | Device: OPTI-FREE PureMoist | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 175 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | Lens Wearing Experience and Biocompatibility of a Marketed Multi-Purpose Disinfecting Solution in Silicone Hydrogel and Soft Contact Lens Wearers |
| Study Start Date : | February 2011 |
| Actual Primary Completion Date : | May 2011 |
| Actual Study Completion Date : | May 2011 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: OPTI-FREE
OPTI-FREE PureMoist multi-purpose contact lens solution used for cleaning, rinsing, disinfecting/storing, and reinserting contact lenses, per protocol-specified regimen
|
Device: OPTI-FREE PureMoist
Commercially marketed multi-purpose contact lens solution for cleaning, rinsing, disinfecting/storing, and reinserting contact lenses |
- Mean Change From Baseline (Day 0) in Average Corneal Staining Area at Day 30 [ Time Frame: Baseline (Day 0), Day 30 ]Percentage corneal staining was assessed by the investigator for each of five regions of the cornea; i.e., four quadrants plus central. The investigator instilled flourescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and yellow filter. Percentage corneal staining was recorded in increments of ten, and the percentages of the five regions were averaged together.
- Mean Change From Baseline (Day 0) in Total Corneal Staining Type at Day 30 [ Time Frame: Baseline (Day 0), Day 30 ]Corneal staining type was assessed by the investigator for each of five regions of the cornea, i.e., four quadrants plus central. The investigator instilled flourescein dye and examined the cornea with a slit lamp, i.e., biomicroscope and yellow filter. Corneal staining type was recorded on a 5-point scale for each region: 0=none; 1=micropunctate; 2=macropunctate; 3=coalesced macropunctate; 4=patch (>/= 1 mm). The five regions were summed, for a summed total range of 0-20.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 18 years or older
- Soft contact lens wear on a daily wear basis
- Able to wear contact lenses for at least 8 hours
- Generally healthy and have normal ocular health
- Other protocol-defined inclusion criteria may apply
Exclusion Criteria:
- No use of additional lens cleaners
- No known sensitivities to any ingredient in the test article
- No history of ocular surgery/trauma within the last six months
- Other protocol-defined exclusion criteria may apply
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01484938
| United States, Texas | |
| Contact Alcon Call Center for Trial Locations | |
| Fort Worth, Texas, United States, 76134 | |
| Study Director: | Jami R Kern | Alcon Research |
| Responsible Party: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT01484938 |
| Other Study ID Numbers: |
C-10-017 |
| First Posted: | December 5, 2011 Key Record Dates |
| Results First Posted: | October 8, 2012 |
| Last Update Posted: | October 10, 2012 |
| Last Verified: | October 2012 |
|
Soft contact lenses Multi-purpose solution Corneal staining |
|
Refractive Errors Eye Diseases |

